Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 601–700 of 1,027

Self-management Counseling in Patients With Heart Failure
Powell, L. H., Calvin, J. E., Richardson, D., Janssen, İ., de Leon, C. F. M., Flynn, K. J., Grady, K. L., Rucker-Whitaker, C. S., Eaton, C., Avery, E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1362 · Cited by 195
Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists
Azizi, M., & Ménard, J. (2004) · Circulation · doi:10.1161/01.cir.0000131449.94713.ad · Cited by 195
Effects of computerized guidelines for managing heart disease in primary care
Tierney, W. M., Overhage, J. M., Murray, M. D., Harris, L. E., Zhou, X., Eckert, G. J., Smith, F. E., Nienaber, N. A., McDonald, C. J., & Wolinsky, F. D. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.30635.x · Cited by 195
Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure
Ekman, I. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1095 · Cited by 195
Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
Oikawa, T., Freeman, M. L., Lo, W., Vaughan, D. E., & Fogo, A. B. (1997) · Kidney International · doi:10.1038/ki.1997.20 · Cited by 195
Diuretics for heart failure
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub4 · Cited by 194
Retracted
Management of Heart Failure
Baker, D. W. (1994) · JAMA · doi:10.1001/jama.1994.03520190074038 · Cited by 194
Evidence of inadequate investigation and treatment of patients with heart failure.
Clarke, K., Gray, D. P., & Hampton, J. R. (1994) · Heart · doi:10.1136/hrt.71.6.584 · Cited by 194
Brugada syndrome: 1992–2002
Antzelevitch, C. N., Brugada, P., Brugada, J., Brugada, R., Towbin, J. A., & Nademanee, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00310-3 · Cited by 193
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
Dickstein, K., Chang, P., Willenheimer, R. B., Haunsø, S., Remes, J., Hall, C., & KJEKSHUS, J. K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80020-h · Cited by 193
Cardiac Function in 5-Year Survivors of Childhood Cancer
van der Pal, H. J. H., van Dalen, E. C., Hauptmann, M., Kok, W. E. M., Caron, H. N., van den Bos, C., Oldenburger, F. R., Koning, C. C. E., van Leeuwen, F. E., & Kremer, L. C. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.233 · Cited by 192
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
Lenzen, M. J., Boersma, E. H., Reimer, W. J. M. S. O., Balk, A. H. M. M., Michel Komajda, N., Swedberg, K. B., Folláth, F., Jiménez-Navarro, M. F., Simoons, M. L., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi499 · Cited by 192
Summary of Recommendations
Priori, S. G. (2002) · EP Europace · doi:10.1053/eupc.2001.0214 · Cited by 192
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 191
Mineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 191
Mechanical Unloading in Heart Failure
Uriel, N. Y., SAYER, G. T., Annamalai, S., Kapur, N. K., & Burkhoff, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.038 · Cited by 191
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Tsutsui, H., Ide, T., Ito, H., Kihara, Y., Kinugawa, K., Kinugawa, S., Makaya, M., Murohara, T., Node, K., Saito, Y., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0431 · Cited by 191
Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy
Bestetti, R. B., & Muccillo, G. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00083-1 · Cited by 191
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
Prins, K. W., Neill, J. M., Tyler, J. O., Eckman, P. M., & Duval, S. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.03.008 · Cited by 190
Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure
Erland, E., Philippe, L., Patricia, V., & Hermann, W. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00174-x · Cited by 190
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
Martens, P., Beliën, H., Dupont, M., Vandervoort, P. M., & Müllens, W. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12435 · Cited by 190
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemia
Leier, C. V., Cas, L. D., & Metra, M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90633-5 · Cited by 190
High incidence of renal artery stenosis in patients with coronary artery disease
Jean, W. J., Al‐Bitar, I., Zwicke, D. L., Port, S. C., Schmidt, D. H., & BAJWA, T. K. (1994) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810320103 · Cited by 189
Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
Groenning, B. A., Raymond, I. E., Hildebrandt, P. R., Nilsson, J. C., Baumann, M., & Pedersen, F. (2004) · Heart · doi:10.1136/hrt.2003.026021 · Cited by 189
Possible involvement of the adipose tissue renin‐angiotensin system in the pathophysiology of obesity and obesity‐related disorders
Goossens, G. H., Blaak, E. E., & van Baak, M. A. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00091.x · Cited by 188
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial
Solomon, S. D., Rice, M. M., Jablonski, K. A., Jose, P. O., DOMANSKI, M. J., Sabatine, M. S., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.592733 · Cited by 188
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
Poole-Wilson, P. A. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 188
Familial dilated cardiomyopathy in the United Kingdom.
Keeling, P. J., Gang, Y., Smith, G., Seo, H., Bent, S., Murday, V. A., Caforio, A. L. P., & McKenna, W. J. (1995) · Heart · doi:10.1136/hrt.73.5.417 · Cited by 188
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction
Heidenreich, P. A., Gubens, M. A., Fonarow, G. C., Konstam, M. A., Stevenson, L. W., & Shekelle, P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.043 · Cited by 187
Heart Failure Care in the Outpatient Cardiology Practice Setting
Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.772228 · Cited by 187
Hyperpolarization-Activated Inward Current in Ventricular Myocytes From Normal and Failing Human Hearts
Hoppe, U. C., Jansen, E., Südkamp, M., & Beuckelmann, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.1.55 · Cited by 187
Advanced Hypertensive Heart Disease in Spontaneously Hypertensive Rats
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.269 · Cited by 187
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
Stack, A. G., & Bloembergen, W. E. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.28588 · Cited by 186
Heart Failure in the 21st Century: A Cardiogeriatric Syndrome
Rich, M. W. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.2.m88 · Cited by 186
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
Causland, F. R. M., Lefkowitz, M. P., Claggett, B. L., Anavekar, N. S., Senni, M., Gori, M., Jhund, P. S., McGrath, M. M., Packer, M., Shi, V. C., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047643 · Cited by 186
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
Park, J. J. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0282 · Cited by 186
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure
Cleland, J. G. F., Erhardt, L., Murray, G. D., Hall, A. S., & Ball, S. (1997) · European Heart Journal · doi:10.1093/eurheartj/18.1.41 · Cited by 186
Maintenance of Serum Potassium with Sodium Zirconium Cyclosilicate (ZS-9) in Heart Failure Patients: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Anker, S. D., Kosiborod, M., Zannad, F. M., Piña, I. L., McCullough, P. A., Filippatos, G. S., van der Meer, P., Ponikowski, P. P., Rasmussen, H. S., Lavin, P. T., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.300 · Cited by 185
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective
Bradham, W. S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00503-x · Cited by 185
Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
van den Broek, S. A. J., van Veldhuisen, D. J., de Graeff, P. A., Landsman, M. L. J., Hillege, H. L., & Lie, K. I. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90619-a · Cited by 185
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K. B., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.115 · Cited by 184
Multicenter Randomized Trial of a Comprehensive Hospital Discharge and Outpatient Heart Failure Management Program
Atienza, F., Anguita, M. P., Martínez‐Alzamora, N., Osca, J., Ojeda, S., Bonet, L. A., Ridocci, F., Vallés, F., & Velasco, J. A. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.11.023 · Cited by 184
Effect of exercise training on heart rate variability in healthy older adults
Stein, P. K., Ehsani, A. A., Domitrovich, P. P., Kleiger, R. E., & Rottman, J. N. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70162-6 · Cited by 184
Gender Differences in Patients with Heart Failure
Strömberg, A., & Mårtensson, J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00002-1 · Cited by 184
Economic Implications of Evidence-Based Prescribing for Hypertension
Fischer, M. A., & Avorn, J. (2004) · JAMA · doi:10.1001/jama.291.15.1850 · Cited by 183
Diastolic heart failure in anaesthesia and critical care
Pirracchio, R., Cholley, B., Hert, S. G. D., Solal, A. C., & Mebazaa, A. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem098 · Cited by 183
Diuretic treatment and diuretic resistance in heart failure
Krämer, B. K., Schweda, F., & Riegger, G. A. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00365-9 · Cited by 182
Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project
Bandak, G., Sang, Y., Gasparini, A., Chang, A. R., Ballew, S. H., Evans, M., Arnlov, J., Lund, L. H., Inker, L. A., Coresh, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005428 · Cited by 181
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial
Colucci, W. S., Kolias, T. J., Adams, K. F., Armstrong, W. F., Ghali, J. K., Gottlieb, S. S., Greenberg, B., Klibaner, M. I., Kukin, M. L., & Sugg, J. E. (2007) · Circulation · doi:10.1161/circulationaha.106.666016 · Cited by 181
Medical Treatment of Aortic Stenosis
Marquis‐Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 181
Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey
Morgan, S., Smith, H. E., Simpson, I. A., Liddiard, G. S., Raphael, H., Pickering, R. M., & Mant, D. (1999) · BMJ · doi:10.1136/bmj.318.7180.368 · Cited by 181
Leitlinien zur Therapie der chronischen Herzinsuffizienz
Hoppe, U. C., Böhm, M., Dietz, R., Hanrath, P., Kroemer, H. K., Osterspey, A., SCHMALTZ, A. A., & Erdmann, E. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0268-4 · Cited by 181
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies* on Coronary Prevention
Wood, D., Backer, G. D., Færgeman, O., Graham, I. M., Mancia, G., & Pyörälà, K. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816100-00003 · Cited by 181
Long-Term Prognosis of Medically Treated Patients with Functional Mitral Regurgitation and Left Ventricular Dysfunction
Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P. M., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., & Margonato, A. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp051 · Cited by 180
Metaanalysis and review of heart failure disease management randomized controlled clinical trials
Whellan, D. J., Hasselblad, V., Peterson, E. D., O’Connor, C. M., & Schulman, K. A. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.09.023 · Cited by 180
Treatment of Hypertension in Patients With Coronary Artery Disease
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000018 · Cited by 180
Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005
Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., & Hernandez, A. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2481 · Cited by 180
Macrophage activation and polarization in post-infarction cardiac remodeling
Энхэевна, Г. А., Rogovskaya, Y. V., Сергеевич, Ш. В., Ребенкова, М. С., Kzhyshkowska, J. G., Popov, S. V., Karpov, R. S., & Ryabov, V. V. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0322-3 · Cited by 180
Trends in Pharmacologic Management of Hypertension in the United States
Manolio, T. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430080067009 · Cited by 180
Canine Idiopathic Dilated Cardiomyopathy. Part I: Aetiology, Clinical Characteristics, Epidemiology and Pathology
Tidholm, A., Häggström, J. U., Borgarelli, M., & Tarducci, A. (2001) · The Veterinary Journal · doi:10.1053/tvjl.2001.0571 · Cited by 179
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
Elgendy, I. Y., Mahtta, D., & Pepine, C. J. (2019) · Circulation Research · doi:10.1161/circresaha.118.313568 · Cited by 179
Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction
Suskin, N., Sheth, T., Negassa, A., & Yusuf, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01195-0 · Cited by 179
The Novel Calcium Sensitizer Levosimendan Activates the ATP-Sensitive K+ Channel in Rat Ventricular Cells
Yokoshiki, H., Katsube, Y., Sunagawa, M., & Sperelakis, N. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36997-6 · Cited by 179
Improvement in exercise capacity of candidates awaiting heart transplantation
Stevenson, L. W., Steimle, A. E., Fonarow, G. C., Kermani, M. S., Kermani, D., Hamilton, M. A., Moriguchi, J. D., Walden, J. A., Tillisch, J. H., Drinkwater, D. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00357-v · Cited by 179
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)
Savarese, G., Bodegård, J., Norhammar, A., Sartipy, P., Thuresson, M., Cowie, M., Fonarow, G. C., Vaduganathan, M., & Coats, A. J. S. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2271 · Cited by 177
Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure
MacDowall, P., Kalra, P. A., O'Donoghue, D. J., Waldek, S., Mamtora, H., & Brown, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11060-1 · Cited by 177
Diabetes mellitus and congestive heart failure
SOLANG, L. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1472 · Cited by 177
Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
Hall, A. S., Murray, G. D., & Ball, S. G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04442-5 · Cited by 177
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population
Luchner, A., Burnett, J. C. J., Jougasaki, M., Hense, H. W., Heid, I. M., Muders, F., Riegger, G. N. A. J., & Schunkert, H. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018080-00018 · Cited by 177
A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS
Domanski, M. J., Krause-Steinrauf, H., Massie, B. M., Deedwania, P., Follmann, D., Kovar, D., Murray, D., Oren, R., Rosenberg, Y., Young, J., et al. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00133-7 · Cited by 176
High output heart failure
Mehta, P. A., & Dubrey, S. W. (2008) · QJM · doi:10.1093/qjmed/hcn147 · Cited by 176
Acute Heart Failure: Clinical Presentation, One-Year Mortality and Prognostic Factors
Rudiger, A., Harjola, V., Müller, A., Mattila, E. J., Säilä, P., Nieminen, M. S., & Folláth, F. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.014 · Cited by 176
Joint British recommendations on prevention of coronary heart disease in clinical practice
Cheesman, M., Leech, G. J., Chambers, J. B., Monaghan, M. J., & Nihoyannopoulos, P. (1998) · Heart · doi:10.1136/hrt.80.2008.1s · Cited by 176
The HOPE Study (Heart Outcomes Prevention Evaluation)
Sleight, P. (2000) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2000.002 · Cited by 176
Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy
ADELSTEIN, E. C., Tanaka, H., Soman, P., Miske, G., Haberman, S. C., Saba, S., & Gorcsan, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq389 · Cited by 175
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure
Magalski, A., Adamson, P. B., Gadler, F., Böehm, M., Steinhaus, D. M., REYNOLDS, D. W., Vlach, K., Linde, C. M., Cremers, B., Sparks, B. S., et al. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.32373 · Cited by 175
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension
Claudio Napoli, A., Sica, V., de Nigris, F., Pignalosa, O., Condorelli, M., Ignarro, L. J., & Liguori, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.025 · Cited by 175
A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart Study
Mattu, R. K., Needham, E. W., Galton, D. J., Frangos, E., Clark, A., & Caulfield, M. J. (1995) · Circulation · doi:10.1161/01.cir.91.2.270 · Cited by 175
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial
RYDEN, L. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2311 · Cited by 174
Efficacy of Enalapril for Prevention of Congestive Heart Failure in Dogs with Myxomatous Valve Disease and Asymptomatic Mitral Regurgitation
Kvart, C., Häggström, J. U., Pedersen, H. D., Hansson, K., Eriksson, A., Järvinen, A., Tidholm, A., Bsenko, K., Ahlgren, E., Lives, M., et al. (2002) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2002.tb01610.x · Cited by 174
National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Masoudi, F. A., Rathore, S. S., Wang, Y., Havranek, E. P., Curtis, J. P., Foody, J. M., & Krumholz, H. M. (2004) · Circulation · doi:10.1161/01.cir.0000138934.28340.ed · Cited by 173
Conventional heart failure therapy in cardiac ATTR amyloidosis
Ioannou, A., Massa, P., Patel, R. K., Razvi, Y., Porcari, A., Rauf, M. U., Jiang, A., Cabras, G., Filisetti, S., Bolhuis, R. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad347 · Cited by 173
Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management
Kearney, M. T., Cotton, J. M., Richardson, P. J., & Shah, A. M. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.903.4 · Cited by 173
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure
Foley, R. N. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.160271.x · Cited by 173
Recent advances involving the renin–angiotensin system
Crowley, S. D., & Coffman, T. M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.023 · Cited by 172
Long-Term Outcomes of Dilated Cardiomyopathy Diagnosed During Childhood
Alexander, P. M. A., Daubeney, P. E. F., Nugent, A. W., Lee, K. J., Turner, C., Colan, S. D., Robertson, T., Davis, A. M., Ramsay, J., Justo, R. N., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002767 · Cited by 172
Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure
Cice, G., Benedetto, A. D., D’Isa, S., D’Andrea, A., Marcelli, D., Gatti, E., & Calabrò, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.105 · Cited by 172
Cardiorenal Syndrome in Acute Decompensated Heart Failure
Sarraf, M., Masoumi, A., & Schrier, R. W. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03150509 · Cited by 172
Long-Term Effects of Ramipril on Cardiovascular Events and on Diabetes
HOPE/HOPE-TOO Study Investigators (2005) · Circulation · doi:10.1161/circulationaha.105.548461 · Cited by 172
Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001
Blackledge, H., Tomlinson, J., & Squire, I. B. (2003) · Heart · doi:10.1136/heart.89.6.615 · Cited by 172
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
Exner, D. V., Dries, D. L., Waclawiw, M. A., Shelton, B., & Domanski, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00675-5 · Cited by 172
Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute m yocardial infarction
Torp-Pedersen, C. T., & Køber, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09374-x · Cited by 171
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation
Mori, J., Basu, R., McLean, B. A., Das, S. K., Zhang, L., Patel, V. B., Wagg, C. S., Kassiri, Z., Lopaschuk, G. D., & Oudit, G. Y. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.966705 · Cited by 170
Cardiotoxicity in Childhood Cancer Survivors: Strategies for Prevention and Management
Harake, D. E., Franco, V. I., Henkel, J. M., Miller, T. L., & Lipshultz, S. E. (2012) · Future Cardiology · doi:10.2217/fca.12.44 · Cited by 170
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
Mack, M. J., Lindenfeld, J. M., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.047 · Cited by 170
The Benefit of Implementing a Heart Failure Disease Management Program
Whellan, D. J., Gaulden, L. H., Gattis, W. A., Granger, B. B., Russell, S. D., Blazing, M. A., Cuffe, M. S., & O’Connor, C. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.18.2223 · Cited by 170
Incident Heart Failure Hospitalization and Subsequent Mortality in Chronic Heart Failure: A Propensity-Matched Study
Ahmed, A., Allman, R. M., Fonarow, G. C., Love, T. E., Zannad, F. M., Dell’Italia, L. J., White, M., & Gheorghiade, M. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.12.001 · Cited by 169
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4
Mori, J., Alrob, O. A., Wagg, C. S., Harris, R. A., Lopaschuk, G. D., & Oudit, G. Y. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00636.2012 · Cited by 169
Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
Gilstrap, L. G., Fonarow, G. C., Desai, A. S., Liang, L., Matsouaka, R., DeVore, A. D., Smith, E. E., Heidenreich, P., Hernandez, A. F., Yancy, C. W., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004675 · Cited by 169
Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction
Packer, M., & McMurray, J. J. V. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2149 · Cited by 169

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks